Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects 18 years of age or older, with diagnosis of chronic dermatitis, able to complete the study and comply with study instructions.~* Female subjects of childbearing potential must have a negative pregnancy test. Sexually active women of childbearing potential participating in the study must have been using a medically acceptable form of contraception~Exclusion Criteria:~* Use of systemic corticosteroid and/or other prohibited medications within 4 weeks of the baseline visit.~* Use of topical corticosteroid therapy and/or other prohibited topical medications within 2 weeks prior to the baseline visit

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- clobetasol propionate foam (Type: EXPERIMENTAL): All subjects receive clobetasol propionate

Based on this trial design, predict the completion outcome and termination type (if applicable).